The Ottawa Hospital Cancer Center

Ottawa, Ontario K1H 8L6

3 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Hepatocellular Carcinoma, Locally Advanced Solid Tumor, Metastatic Pancreatic Cancer, Metastatic Solid Tumor, Prostate Cancer, Solid Tumors, mCRPC

Studies at this site

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer — Recruiting now
• A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation — Recruiting now
• A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1) — Recruiting now
• Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC — Running, not enrolling
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) — Completed
• M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer — Stopped early
• An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed